Ad is loading...
JEPCX
Price
$14.87
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
MENRX
Price
$10.15
Change
-$0.00 (-0.00%)
Updated
Nov 21 closing price
Ad is loading...

JEPCX vs MENRX

Header iconJEPCX vs MENRX Comparison
Open Charts JEPCX vs MENRXBanner chart's image
JPMorgan Equity Premium Income C
Price$14.87
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Madison Covered Call & Equity Income R6
Price$10.15
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
JEPCX vs MENRX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEPCX vs. MENRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEPCX is a StrongBuy and MENRX is a Buy.

FUNDAMENTALS
Fundamentals
JEPCX has more cash in the bank: 6.47B vs. MENRX (245M). MENRX pays higher dividends than JEPCX: MENRX (7.54) vs JEPCX (6.58). JEPCX was incepted earlier than MENRX: JEPCX (6 years) vs MENRX (12 years). JEPCX is a more actively managed with annual turnover of: 189.00 vs. MENRX (102.00). JEPCX has a lower initial minimum investment than MENRX: JEPCX (1000) vs MENRX (500000). JEPCX annual gain was more profitable for investors over the last year : 16.48 vs. MENRX (8.36). MENRX return over 5 years is better than : 61.66 vs. JEPCX (52.74).
JEPCXMENRXJEPCX / MENRX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence6 years12 years-
Gain YTD13.3495.382248%
Front LoadN/AN/A-
Min. Initial Investment10005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.47B245M2,642%
Annual Yield % from dividends6.587.5487%
Returns for 1 year16.488.36197%
Returns for 3 years22.9020.58111%
Returns for 5 years52.7461.6686%
Returns for 10 yearsN/A69.12-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ODP26.630.77
+2.98%
ODP Corp (The)
FMC58.331.13
+1.98%
FMC Corp
ZVRA9.130.16
+1.78%
Zevra Therapeutics
IKNA1.730.03
+1.76%
Ikena Oncology
AVGO163.940.69
+0.42%
Broadcom Inc.